Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CLAL INSURANCE ENTERPRISES HOLDINGS LTD. (CLIS)

  • Business News
  • June 03, 2026, 06:16 UTC
  • 5
  • 1 comments

Events and transactions

Market reaction Comment Full text

AMOT INVESTMENTS LTD. (AMOT)

  • Business News
  • June 03, 2026, 06:16 UTC
  • 3
  • 1 comments

Change in holdings of interested parties/officers

Market reaction Comment Full text

FERRARI N.V. (RACE)

  • Business News
  • June 03, 2026, 06:14 UTC
  • 4
  • 1 comments

RENEWAL OF THE AGREEMENT BETWEEN SCUDERIA FERRARI HP AND CHARLES LECLERC

Market reaction Comment Full text

HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. (HARL)

  • Business News
  • June 03, 2026, 06:13 UTC
  • 4
  • 1 comments

Dormant shares – change in the number of shares

Market reaction Comment Full text

SELLA CAPITAL REAL ESTATE LTD (SLARL)

  • Business News
  • June 03, 2026, 06:10 UTC
  • 3
  • 1 comments

Dividend in the amount of 14.25 agorot per share, record date 12.6.26, payment 30.6.26

Market reaction Comment Full text

MESHEK ENERGY-RENEWABLE ENERGIES LTD (MSKE)

  • Business News
  • June 03, 2026, 06:09 UTC
  • 3
  • 1 comments

Started to be an interested party - Migdal Insurance and Finance Holdings Ltd.

Market reaction Comment Full text

Novo Nordisk (NVO)

  • Business News
  • June 03, 2026, 06:06 UTC
  • 3
  • 1 comments

Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

Market reaction Comment Full text

G CITY LTD (GCT)

  • Business News
  • June 03, 2026, 06:05 UTC
  • 3
  • 1 comments

Self purchase/sale of securities

Market reaction Comment Full text

ENERGEAN PLC (ENOG)

  • Business News
  • June 03, 2026, 06:00 UTC
  • 3
  • 1 comments

Other Report or Announcement

Market reaction Comment Full text

BANCO SANTANDER S.A. (SAN)

  • Business News
  • June 03, 2026, 06:00 UTC
  • 3
  • 1 comments

Communiqué de presse : Sanofi fédère lécosystème de santé pour accélérer le diagnostic des maladies rares en France : Biogen rejoint accelRare

Market reaction Comment Full text
  • Previous
  • 1122
  • 1123
  • 1124
  • 1125
  • 1126
  • Next

Search

News categories

  • Technical Exchange News(13379)
  • Event(6229)
  • SEC News(342218)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(189469)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin